omitir hasta el contenido
Prescription drugs Ver este material de antemano
CerrarVer este material de antemano
Chequeando…

Prescription drugs

Autor: Sylvia Engdahl
Editorial: Detroit : Greenhaven Press/Gale Cengage Learning, ©2008.
Serie: Current controversies.
Edición/Formato:   Libro : Inglés (eng)Ver todas las ediciones y todos los formatos
Base de datos:WorldCat
Calificación:

(todavía no calificado) 0 con reseñas - Ser el primero.

Temas
Más materiales como éste

 

Encontrar un ejemplar en la biblioteca

&AllPage.SpinnerRetrieving; Encontrando bibliotecas que tienen este material…

Detalles

Formato físico adicional: Online version:
Prescription drugs.
Detroit : Greenhaven Press/Gale Cengage Learning, c2008
(OCoLC)768252756
Tipo de material: Recurso en Internet
Tipo de documento: Libro/Texto, Recurso en Internet
Todos autores / colaboradores: Sylvia Engdahl
ISBN: 9780737739626 0737739622 9780737739633 0737739630
Número OCLC: 192079717
Descripción: 246 p. ; 24 cm.
Contenido: Is too little attention given to the safety of prescription drugs? Yes : Problems often show up after a prescription drug is on the market. Off-label prescription of drugs can lead to adverse effects / Hazel Muir --
Some prescription drugs on the market are unsafe / Consumer reports --
Prescription drugs can cause serious harm when risks are ignored / Susan Kelleher --
Post-marketing study of prescription drugs is not adequate / David J. Graham --
No : Too much caution deprives patients of prescription drugs they need. Excessive caution in drug approval causes more harm than it prevents / Scott Gottlieb --
Panic over prescription-drug risks leads people to stop taking needed medication / Irene S. Levine --
Safety concerns about prescription drugs are exaggerated and will result in higher prices / Henry I. Miller --
Lengthy approval process for prescription drugs costs lives / Gilbert L. Ross --
Terminally ill patients should be allowed to use experimental drugs / Sigrid Fry-Revere --
Do pharmaceutical companies promote unnecessary drugs? Direct-to-consumer prescription drug advertising : an overview / Carol Rados --
Yes : Many new drugs are developed merely for commercial reasons. Pharmaceutical companies define normal conditions as diseases / Ray Moynihan, Alan Cassels --
Drug promotion plays on people's fears of future illness / Barbara Mintzes --
Drug promotion has led to the overmedication of children / Anne Taylor Fleming --
No : New drugs help people who would otherwise lack effective treatment. Drugs for minor conditions are important to many people / Glenn Harlan Reynolds --
Improved prescription drugs mean better medical treatment and less illness / Alan F. Holmer --
Direct-to-consumer prescription drug advertising helps people get treatment for undiagnosed diseases / Paul Antony. Do prescription drugs in America cost too much? Rising cost of prescription drugs : an overview --
Yes : American pharmaceutical companies charge too much. Many people cannot afford the prices set by the profit-driven drug industry / Katharine Greider --
Importing less-costly prescription drugs from abroad should be allowed / Nelda Barnett --
New cancer drugs cost more than their brief extending of life may be worth / Daniel Costello --
No : pharmaceutical companies need profits to do research. High prices of drugs for minor problems pay for drugs that cure more serious ones / Peter W. Huber --
Medical innovation would stop if the government controlled drug prices / Sidney Taurel --
Controlling drug prices would reduce access to medicine / Doug Bandow --
Are dishonest or illegal prescription drug practices common? Gifts from pharmaceutical companies influence doctors / Adriane Fugh-Berman, Shahram Ahari --
Media reporting about prescription drugs is often inaccurate / Richard A. Deyo, Donald L. Patrick --
Prescription drugs are often abused / Nichole Aksamit --
Young people often trade prescription drugs with friends / Amy Harmon --
Teens use prescription drugs to get high / Donna Leinwand.
Título de la serie: Current controversies.
Responsabilidad: Sylvia Engdahl, book editor.
Más información:

Reseñas

Reseñas contribuidas por usuarios
Recuperando reseñas de GoodReads…
Recuperando reseñas de DOGObooks…

Etiquetas

Ser el primero.

Materiales similares

Temas relacionados:(3)

Listas de usuarios con este material (2)

Confirmar este pedido

Ya ha pedido este material. Escoja OK si desea procesar el pedido de todos modos.

Datos enlazados


<http://www.worldcat.org/oclc/192079717>
library:oclcnum"192079717"
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/192079717>
rdf:typeschema:Book
schema:about
<http://id.worldcat.org/fast/1060129>
rdf:typeschema:Intangible
schema:name"Pharmaceutical industry"@en
schema:name"Pharmaceutical industry."@en
schema:about
<http://id.worldcat.org/fast/1060194>
rdf:typeschema:Intangible
schema:name"Pharmaceutical policy"@en
schema:name"Pharmaceutical policy."@en
schema:about
schema:about
schema:about
schema:about
<http://id.worldcat.org/fast/898888>
rdf:typeschema:Intangible
schema:name"Drugs--Public opinion"@en
schema:name"Drugs--Public opinion."@en
schema:about
schema:about
schema:contributor
schema:copyrightYear"2008"
schema:datePublished"2008"
schema:exampleOfWork<http://worldcat.org/entity/work/id/119960281>
schema:inLanguage"en"
schema:name"Prescription drugs"@en
schema:numberOfPages"246"
schema:publisher
schema:url
schema:workExample
schema:workExample

Content-negotiable representations

Cerrar ventana

Inicie una sesión con WorldCat 

¿No tienes una cuenta? Puede fácilmente crear una cuenta gratuita.